326 related articles for article (PubMed ID: 16573774)
21. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
[TBL] [Abstract][Full Text] [Related]
22. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
[TBL] [Abstract][Full Text] [Related]
23. Abdominal pain impacts quality of life in women with irritable bowel syndrome.
Cain KC; Headstrom P; Jarrett ME; Motzer SA; Park H; Burr RL; Surawicz CM; Heitkemper MM
Am J Gastroenterol; 2006 Jan; 101(1):124-32. PubMed ID: 16405544
[TBL] [Abstract][Full Text] [Related]
24. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome.
Gonsalkorale WM; Toner BB; Whorwell PJ
J Psychosom Res; 2004 Mar; 56(3):271-8. PubMed ID: 15046962
[TBL] [Abstract][Full Text] [Related]
25. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
26. The spectrum of irritable bowel syndrome: A clinical review.
Gilkin RJ
Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443
[TBL] [Abstract][Full Text] [Related]
27. A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome.
Blanchard EB; Lackner JM; Sanders K; Krasner S; Keefer L; Payne A; Gudleski GD; Katz L; Rowell D; Sykes M; Kuhn E; Gusmano R; Carosella AM; Firth R; Dulgar-Tulloch L
Behav Res Ther; 2007 Apr; 45(4):633-48. PubMed ID: 16979581
[TBL] [Abstract][Full Text] [Related]
28. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment.
Drossman D; Morris CB; Hu Y; Toner BB; Diamant N; Whitehead WE; Dalton CB; Leserman J; Patrick DL; Bangdiwala SI
Am J Gastroenterol; 2007 Jul; 102(7):1442-53. PubMed ID: 17509027
[TBL] [Abstract][Full Text] [Related]
29. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
Mangel AW; Bornstein JD; Hamm LR; Buda J; Wang J; Irish W; Urso D
Aliment Pharmacol Ther; 2008 Jul; 28(2):239-49. PubMed ID: 18466359
[TBL] [Abstract][Full Text] [Related]
30. Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients.
Schmulson M; Chang L; Naliboff B; Lee OY; Mayer EA
Am J Gastroenterol; 2000 Jan; 95(1):152-6. PubMed ID: 10638575
[TBL] [Abstract][Full Text] [Related]
31. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
Lindfors P; Ljótsson B; Bjornsson E; Abrahamsson H; Simrén M
Neurogastroenterol Motil; 2013 Feb; 25(2):169-e86. PubMed ID: 23051178
[TBL] [Abstract][Full Text] [Related]
32. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life.
Kearney DJ; McDermott K; Martinez M; Simpson TL
Aliment Pharmacol Ther; 2011 Aug; 34(3):363-73. PubMed ID: 21651595
[TBL] [Abstract][Full Text] [Related]
33. Reported sexual abuse predicts impaired functioning but a good response to psychological treatments in patients with severe irritable bowel syndrome.
Creed F; Guthrie E; Ratcliffe J; Fernandes L; Rigby C; Tomenson B; Read N; Thompson DG
Psychosom Med; 2005; 67(3):490-9. PubMed ID: 15911915
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
36. Symptom experience, psychological distress, and quality of life in Korean patients with liver cirrhosis: a cross-sectional survey.
Kim SH; Oh EG; Lee WH
Int J Nurs Stud; 2006 Nov; 43(8):1047-56. PubMed ID: 16952363
[TBL] [Abstract][Full Text] [Related]
37. Analyzing the content of outcome measures in clinical trials on irritable bowel syndrome using the international classification of functioning, disability and health as a reference.
Schönrich S; Brockow T; Franke T; Dembski R; Resch KL; Cieza A
Rehabilitation (Stuttg); 2006 Jun; 45(3):172-80. PubMed ID: 16755436
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.
Ringel Y; Williams RE; Kalilani L; Cook SF
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113
[TBL] [Abstract][Full Text] [Related]
39. Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study.
Ringström G; Störsrud S; Posserud I; Lundqvist S; Westman B; Simrén M
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):420-8. PubMed ID: 19923998
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.
Moss-Morris R; McAlpine L; Didsbury LP; Spence MJ
Psychol Med; 2010 Jan; 40(1):85-94. PubMed ID: 19531276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
